comparative effectiveness research

News

Optimal Real-World Immunochemotherapy Regimen for Patients With MCL

06/25/2020

A study presented at the European Hematology Association (EHA) Annual Meeting (June 11-21, 2020) shed light on real-world outcomes in patients with mantle cell lymphoma (MCL) who were treated with rituximab plus...

A...

06/25/2020

Journal of Clinical Pathways

Conference Coverage

2016 Genitourinary Cancers Symposium

01/28/2016

JCP Editors

The American Society of Clinical Oncology’s 2016 Genitourinary Cancers Symposium was held earlier this month (January 7-9) in San Francisco, California, where the brightest professionals in urology, oncology, and...

The...

01/28/2016

Journal of Clinical Pathways

Research in Review

Immunotherapy Drug Improves Overall Survival in Patients With NSCLC

12/30/2015

JCP Editors

Favorable results for pembrolizumab, a PD-1/PD-L1 inhibitor only recently approved for the treatment of non-small-cell lung cancer (NSCLC), were found in a trial comparing the drug’s effectiveness to that of the...

...

12/30/2015

Journal of Clinical Pathways

Research in Review

Earlier Chemotherapy Improves Outcomes for Patients With Prostate Cancer

12/30/2015

JCP Editors

Results from a recent clinical trial have shown that earlier chemotherapy treatment may lead to improved outcomes for prostate cancer patients initiating long-term hormone therapy. A paper published in Lancet...

...

12/30/2015

Journal of Clinical Pathways